Strides Pharma posts consolidated net loss at Rs 82 crore in Q3 Ruchika Sharma26 Jan 2023 8:30 AM GMTNew Delhi: Strides Pharma Science has reported a consolidated net loss of Rs 82 crore for the third quarter ended December 31, 2022.The drug firm had...
Strides Pharma Science successfully concludes WHO inspection at Puducherry facility Ruchika Sharma23 Jan 2023 8:45 AM GMTBengaluru: Strides Pharma Science Limited has announced that the company has successfully completed the inspection carried out by the World...
Strides Pharma Science biologics arm gets USFDA EIR for Bengaluru facility Ruchika Sharma18 Jan 2023 6:48 AM GMTBengaluru: Stelis Biopharma Limited, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm...
Stelis Biopharma CDMO partner gets USFDA nod for key ANDA Ruchika Sharma28 Dec 2022 9:49 AM GMTBengaluru: Stelis Biopharma Limited, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm of...
Strides Pharma Science biologics arm gets EMA nod for osteoporosis drug Kauliv Ruchika Sharma14 Nov 2022 7:00 AM GMTKauliv is a biosimilar to Forsteo (innovator product), indicated for both men and postmenopausal women with osteoporosis who are at high risk for...
Strides Pharma arm gets EIR from USFDA for Bengaluru facility Ruchika Sharma1 Sep 2022 7:00 AM GMTThe Unit 2 facility has high-end automated DP lines integrated with isolators to convert drug substances (DS) into stable formulations and fill finish...
Strides Pharma secures USFDA nod for pain relief drug Ruchika Sharma18 Aug 2022 12:12 PM GMTNaproxen Sodium Softgel Capsules can also be used to treat acute pain caused by other conditions.
Strides successfully concludes USFDA inspection at Singapore facility Ruchika Sharma10 Aug 2022 5:30 AM GMTBengaluru: Strides Pharma Science Limited has announced that its formulation facility at Singapore underwent a US Food and Drug Administration...
Strides Pharma Science arm bags USFDA nod for Cyclosporine Softgel Capsules Ruchika Sharma3 Aug 2022 9:30 AM GMTThe product will be manufactured at the company's facility at Bengaluru and will be marketed by Strides Pharma Inc. in the US market.
Stride Pharma Science Q1 revenue Grows 36.6 percent Ruchika Sharma31 July 2022 4:30 AM GMTRevenue from operations during the quarter under review stood at Rs 940.07 crore as compared to Rs 688.37 crore in the year-ago period, a growth of...
Board of Strides Pharma Science to consider fund raising through securities issuance Ruchika Sharma21 July 2022 7:45 AM GMTThe Bengaluru-based company did not share details of the amount proposed to be raised.
Strides Pharma bags USFDA nod for pain relief drug Ruchika Sharma30 May 2022 6:21 AM GMTThe medicine will be manufactured at the company’s facility at Bengaluru and will be marketed by Strides Pharma Inc. in the US market.
